ATP is co-localized with norepinephrine at the sympathetic nerve terminals and may be released simultaneously upon neuronal stimulation, which results in activation of purinergic receptors. To examine whether leptin synthesis and lipolysis are influenced by P2 purinergic receptor activation, the effects of ATP and other nucleotides on leptin secretion and glycerol release have been investigated in differentiated rat white adipocytes. Firstly, insulin-induced leptin secretion was inhibited by nucleotide treatment with the following efficacy order: 3-O-(4-benzoyl)benzoyl ATP (BzATP) > ATP > > UTP. Secondly, treatment of adipocytes with ATP increased both intracellular Ca 2؉ concentration and cAMP content. Intracellular calcium concentration was increased by ATP and UTP, but not BzATP, an effect attributed to phospholipase C-coupled P2Y 2 . On the other hand, cAMP was generated by treatment with BzATP and ATP␥S, but not UTP, indicating functional expression of adenylyl cyclase-coupled P2Y 11 receptors in white adipocytes. Thirdly, lipolysis was significantly activated by BzATP and ATP, which correlated with the characteristics of the P2Y 11 subtype. Taken together, the data presented here suggest that white adipocytes express at least two different types of P2Y receptors and that activation of P2Y 11 receptor might be involved in inhibition of leptin production and stimulation of lipolysis, suggesting that purinergic transmission can play an important role in white adipocyte physiology.
key enzyme for the mobilization of triglycerides deposited in adipose tissue. HSL-mediated lipolysis is stimulated by catecholamines and other lipolytic hormones with phosphorylation of HSL by cAMP-dependent protein kinase A and perilipinmediated translocation of the enzyme from the cytoplasm to the lipid droplet (1) (2) (3) (4) . Dysregulation of the lipolytic pathway has been one of the major hypotheses linking insulin resistance to hyperlipidemia in metabolic disease, obesity, and diabetes mellitus (5, 6) . Recently, identification of molecules that control food intake has generated new targets for drug development in the treatment of obesity and related disorders (7) . Leptin is a 16-kDa hydrophilic protein mainly secreted from white adipocytes, which is considered to signal the size of adipose tissue stores to the brain and plays a key role in regulating body weight (8, 9) . Leptin has widespread effects on other physiological responses such as immune function, hematopoiesis, angiogenesis, renal function, reproduction, and neuroendocrine function (10) . Therefore, an understanding the regulation of two important adipocyte-specific physiological processes, lipolysis and leptin production, is very important.
It is well known that the sympathetic nervous system is involved in the regulation of lipolysis and mobilization of lipid stores from white adipose tissue and is a key regulator of leptin production (11, 12) . Several studies have shown that ␤-adrenergic receptor mediates the effect of the sympathetic nervous system on leptin expression by activating cyclic AMP (cAMP)/ protein kinase A signaling pathways (13, 14) . Previously, Lee and Pappone (15) suggested that other neuronal factors besides the adrenergic system may also be involved in the sympathetic activity and proposed extracellular ATP as a candidate, because it is often co-localized in the vesicles of many sympathetic neurons and is released simultaneously with norepinephrine. The various physiological effects of P2 purinergic receptor stimulation have been well studied in brown adipocytes, including increases in cytosolic calcium levels and membrane conductance (16) , enhancement of cellular metabolism (17) , stimulation of exocytosis (18) , and regulation of cell proliferation (19) . These all indicate ATP is a factor that mediates important aspects of sympathetic stimulation in brown adipocytes. However, little is known about the effects of purinergic activation on white adipocytes. Therefore, to define the signal transduction of purinergic receptors and their physiological roles in rat white adipocytes, we tested the effects of purinergic agonists on the levels of intracellular calcium and cAMP and two important aspects of adipocyte-specific physiology, lipolysis, and leptin production. Here we report that extracellular ATP elicits the elevation of cAMP and cytosolic Ca 2ϩ through the activation of two different purinergic receptors, P2Y 2 and P2Y 11 . The activation of cAMP-protein kinase A signaling pathways with the stimulation of P2Y 11 increases lipolysis and decreases leptin production.
EXPERIMENTAL PROCEDURES
Materials-ATP, UTP, ␣,␤-methylene ATP, adenosine 5Ј-O-(3-thiotriphosphate) (ATP␥S), (Ϯ)-sulfinpyrazone, Triton X-100, EGTA, EDTA, Trizma base, trichloroacetic acid, bovine serum albumin, collagenase Type II, and inositol 1,4,5-trisphosphate (IP 3 ) were purchased from Sigma-Aldrich (St. Louis, MO). Medium 199 (M199), fetal bovine serum, and antibiotics were purchased from Invitrogen. Fura-2 pentaacetoxymethyl ester (fura-2/AM) and fluo-4 acetoxmethyl ester (fluo-4/ AM) were purchased from Molecular Probes (Eugene, OR). [␣-
32 P]dCTP was obtained from PerkinElmer Life Sciences. The anti-HSL antibody was a kind gift from Dr. Constantine Londos (National Institutes of Health).
Cell Culture-Fibroblastic preadipocytes were isolated from adipose tissue and cultured according to a previously reported method (20) . The inguinal fat pads from 14-day-old male Sprague-Dawley rats (8 per group) were removed under sterile conditions and washed in a buffer containing 135 mM NaCl, 4.7 mM KCl, 2.5 mM CaCl 2 , 1.25 mM MgSO 4 , 10 mM HEPES, 1.25 mM NaH 2 PO 4 , 1.25 mM Na 2 HPO 4 , and 1% (w/v) bovine serum albumin. The fat pads were transferred to fresh buffer containing collagenase type II (1 mg/ml), 3.5% (w/v) bovine serum albumin, and glucose (0.5 mg/ml). Following incubation for 1 h at 37°C in a shaking water bath, the digest was filtered through sterile 250-mm nylon mesh. The digested tissue was centrifuged at 250 ϫ g for 10 min, and mature adipocytes were removed by aspiration. The pellet containing the stromal-vascular fraction was resuspended in M199 supplemented with penicillin, streptomycin, and fungizone (100 units/ml, 100 mg/ml, and 2.5 mg/ml, respectively), and refiltered. Red blood cells were lysed by hypotonic shock (21) . The suspension was centrifuged (250 ϫ g for 10 min) and cells were counted using a hemocytometer. The cell preparation (mainly fibroblastic preadipocytes) was adjusted to a density of 1.5 ϫ 10 5 cells/ml in M199 containing 10% fetal calf serum. After 48 h at 37°C in an atmosphere of 5% CO 2 , differentiation was induced by addition of medium supplemented with 0.5 mM isobutylmethylxanthine, 0.25 M dexamethasone, and 10 g/ml insulin. After another 48 h, the induction medium was removed and replaced by M199 containing 10% fetal calf serum supplemented with insulin (10 g/ml) alone (22) . The medium was changed every 2 days. Fully differentiated adipocytes were obtained after treatment with the above medium containing insulin for 7 days.
Preparation of Epididymal Adipocytes-Epididymal adipocytes were isolated by collagenase digestion of the epididymal fat pads of male Sprague-Dawley rats (45) and after being washed free of enzyme, were suspended 1:5 (v/v) in Krebs-Ringer phosphate buffer containing 1% bovine serum albumin and 5 mM glucose. Aliquots of cell suspension (600 ml) were incubated without or with each nucleotide for lipolysis and incubated in a quartz cuvette with 10 M fura-2/AM at 37°C for 40 min under continuous stirring for calcium measurement.
Western Blot Analysis-Adipocytes were plated in 60-mm tissue culture dishes and treated with nucleotides for various times as indicated. After treatment, the cells were washed twice with cold phosphatebuffered saline and then lysed with lysis buffer (250 mM Tris-Cl (pH 6.5), 2% SDS, 4% ␤-mercaptoethanol, 0.02% bromphenol blue, and 10% glycerol). Equivalent amounts of proteins were resolved by SDS-PAGE and analyzed by Western blotting. Immunoblot analysis was performed as we previously described (32) . Signals were detected with an ECL detection system (Neuronex Co., Korea).
Determination of Intracellular Ca 2ϩ Level-The level of intracellular Ca 2ϩ was measured using the fluorescence Ca 2ϩ indicator fura-2/AM as previously described (23) . Briefly, after the differentiated adipocytes were harvested from 100-mm culture plates by 0.25% (w/v) trypsinization, the cells were washed with serum-free M199 medium. Then cell suspensions were incubated in a quartz cuvette with 3 M fura-2/AM at 37°C for 40 min under continuous stirring. The cells were then resuspended in Locke's solution (154 mM NaCl, 5.6 mM KCl, 2.2 mM CaCl 2 , 1.2 mM MgCl 2 , 10 mM glucose, and 5 mM HEPES, pH 7.4). In Ca 2ϩ -free Locke's solution, CaCl 2 was omitted, and 100 M EGTA was included. Sulfinpyrazone (250 M) was added to all solutions to prevent dye leakage (24) . Changes in fluorescence ratio were measured at the dual excitation wavelengths of 340 nm and 380 nm and the emission wavelength of 500 nm. [Ca 2ϩ ] i was calculated using the equation
, where R max and R min are the ratios obtained when fura-2 is saturated with Ca 2ϩ and when EGTA is used to remove Ca 2ϩ , respectively. To obtain R min and R max , the fluorescence ratios of the cell suspension were measured successively at final concentrations of 4 mM EGTA, 30 mM Trizma base, 0.1% Triton X-100, and 4 mM CaCl 2 . S f2 and S b2 are the proportionality coefficients of Ca 2ϩ -free fura-2 and saturated fura-2, respectively. Calibration of the fluorescence signal in terms of [Ca 2ϩ ] i was performed according to the method of Grynkiewicz et al. (25) .
Confocal Microscopy-To record fluorescence images, adipocytes cultured on poly-D-lysine-coated coverslips were loaded with 5 M fluo-4/AM dye. After incubation for 30 min at 37°C, cells were washed two times in Locke's solution to remove excess dye. Adipocytes containing lipid droplets were selected under the microscope. Measurements of intracellular calcium were performed with the Bio-Rad Radiance 2100 confocal microscope (Bio-Rad) equipped with a ϫ40 objective 0.75 numerical aperture. The calcium-sensitive Fluo-4 dye was excited by the 488 nm line from an argon laser, and the emission fluorescence monitored at 515/30 nm was selected by a band-pass filter. During fluorescence data collection, each scan of a 512 ϫ 512 pixel image took 0.35 s, and the interval between each image scan was ϳ5 s. Images were stored and processed with laser pix software (Bio-Rad). 3 competition assay as we previously described (23) . To determine the IP 3 concentration, mature adipocytes were stimulated with agonists for the indicated periods of time, and the reaction was terminated by aspirating the medium off the cells followed by addition of 0.3 ml of ice-cold 15% (w/v) trichloroacetic acid containing 10 mM EGTA. The samples were left on ice for 30 min to extract water-soluble inositol. The extract was then transferred to an Eppendorf tube, and trichloroacetic acid was removed by four times of extractions with diethyl ether. Finally, the extract was neutralized with 200 mM Trizma base, and its pH was adjusted to about 7.4. 20 l of the cell extract was added to 20 l of assay buffer (0.1 M Tris buffer containing 4 mM EDTA and 4 mg/ml bovine serum albumin) and 20 l of [ 3 H]IP 3 (0.1 Ci/ml). Then 20 l of solution containing the binding protein was added, and the mixture was incubated for 15 min on ice and centrifuged at 20,000 ϫ g for 5 min. The pellet was resuspended in 100 l of water, and 1 ml of scintillation mixture was added to measure the radioactivity. IP 3 concentration in each sample was determined based on a standard curve and expressed as picomoles/g of protein.
The IP 3 -binding protein was prepared from bovine adrenal cortex according to the method of Challiss et al. (26) . Briefly, the adrenal cortex obtained freshly from local slaughter house was demedullated and decapsulated, and the remaining cortex was homogenized in homogenization buffer (1.68 g of NaHCO 3 and 0.16 g of dithiothreitol per liter, pH 8.0). The homogenate was centrifuged at 5,000 ϫ g for 15 min at 4°C. The supernatant fraction is harvested and recentrifuged at 38,000 ϫ g for 20 min at 4°C. The supernatant was discarded, and the pellet was resuspended in the buffer and rehomogenized with glass homogenizer. The protein concentration was about 20 mg/ml as determined by BCA protein assay.
Measurement of [ 3 H]cAMP-Intracellular cAMP generation was determined by [
3 H]cAMP competition assay as we described previously (27) with some modification. To determine the cAMP production induced by agonists, white adipose cells were stimulated with agonists for 20 min in the presence of the phosphodiesterase inhibitor Ro 20-1724 (5 M), and the reaction was quickly terminated by three repeated cycles of freezing and thawing. The samples were then centrifuged at 22,000 ϫ g for 5 min at 4°C. The cAMP assay is based on the competition between 3 H-labeled cAMP and unlabeled cAMP present in the sample for binding to a crude cAMP-binding protein prepared from bovine adrenal cortex according to the method of Brown et al. (28) . Each sample was incubated with 50 l of 3 H-labeled cAMP (5 Ci) and 100 l of binding protein for 2 h at 4°C. Separation of the protein-bound cAMP from the unbound cAMP was achieved by adsorption of the free cAMP into charcoal (100 l) followed by centrifugation at 22,000 ϫ g at 4°C. 1.2 ml of scintillation mixture was added to 200 l of supernatant to measure the radioactivity. The cAMP concentration in the sample was determined based on a standard curve and expressed as picomoles.
RNA Extraction, Northern Blot Analysis, and Quantitative Real-time Reverse Transcription-PCR-Total RNA was extracted from differenti-ated adipocytes using TRIzol reagent (Molecular Research Center, Inc., Cincinnati, OH) according to the manufacturers' protocol. Northern blot analysis was performed as previously described (51) . For quantitative real-time PCR, total RNA was reversely transcribed using an iScript TM cDNA synthesis kit (Bio-Rad) according to the manufacturers' instructions. For detection and quantification, a MyiQ TM real-time PCR detection system (Bio-Rad) was used. PCR reactions were performed using an iQTM SYBR Green Supermix kit (Bio-Rad). PCR was carried out in a final volume of 20 l using 0.5 M of each primer, cDNA, and 10 l of the supplied enzyme mixture containing the DNA double strand-specific SYBR Green I dye for detection of PCR products. PCR was performed with a 3-min preincubation at 95°C followed by 40 cycles of 30 s at 95°C, 30 s at 58°C, and 30 s at 72°C. PCR products were verified by melting curve analysis, agarose gel electrophoresis, and DNA sequencing. The following primers were used: glyceraldehyde-3-phosphate dehydrogenase (forward, 5Ј-GCCATCAATGACCCCTTC-ATT; reverse, 5Ј-GCTCCTGGAAGATGGTGATGG) leptin (forward, 5Ј-TCACCCCATTCTGAGTTTTGTC; reverse, 5Ј-CGCCATCCAGGCTCT-CT). Relative value of gene expression was analyzed using the 2-⌬⌬C(T) method (29) .
Measurement of Leptin Production-By using cultured rat adipocytes grown in 12-well plates, we measured the effects of various nucleotides on leptin production. Leptin concentration in the medium was determined using a sensitive and specific rat leptin RIA kit (Linco Inc., St. Charles, MO).
Lipolysis Measurements-Glycerol release was measured as previously described (30) . Briefly, the differentiated adipocytes cultured in 24-well plates (in M199 medium) were stimulated with agents for the indicated time period in the figure legends. After stimulation, 1 ml of hydrazine buffer containing 50 mM glycine, pH 9.8, 0.05% hydrazine hydrate, 1 mM MgCl 2 supplemented with 0.75 mg/ml ATP, 0.375 mg/ml NAD, 25 g/ml glycerol-3-phosphate dehydrogenase, and 0.5 g/ml glycerol kinase was added to 200 l of collected media. After incubation for 40 min at room temperature, absorbance was measured at 340 nm, and glycerol release was calculated.
Preparation of Cytosolic and Fat Cake Fractions for SDS-PAGECytosolic and fat cake fraction from adipocytes were obtained for immunoblot as described previously (2) . Briefly, after differentiated adipocytes in 100-mm culture plates were stimulated as indicated, the cells were lysed in 150 l of ice-cold 50 mM Tris-HCl buffer, pH 7.4, containing 225 mM sucrose, 1 mM EDTA, 1 mM benzamidine, 1 g/ml pepstatin, 1 g/ml leupeptin, 1 g/ml antipain, and 50 mM NaF (buffer A). Following lysis, cells were kept on ice for 15 min for the floating fat cake to solidify. The lysate was then vortexed vigorously and centrifuged at 13,000 ϫ g at 4°C for 15 min. The cytosolic fraction was aspirated from the solidified fat cake below, and 100 l of cytosol was added to an equal volume of ϫ2 sample buffer for SDS-PAGE. The fat cake fraction was respun at 13,000 ϫ g at 4°C for 15 min, and any contaminating cytosol was aspirated and discarded. The fat cake was warmed to room temperature, 100 l of SDS sample buffer was added, and the solution was vortexed thoroughly. Following centrifugation at 13,000 ϫ g at 4°C for 15 min, the fat cake protein extract was aspirated from the floating fat layer below for PAGE.
Analysis of Data-All quantitative data are expressed as mean Ϯ S.E. Comparison between two groups was analyzed using Student's unpaired t test, and differences were considered to be significant when p was Ͻ0.05.
RESULTS
Adipogenic Differentiation-Fibroblastic preadipocytes were harvested from the subcutaneous fat depot of suckling rats, cultured, and induced to differentiate into mature adipocytes (20) . After induction by treating cells with dexamethasone, isobutylmethylxanthine and insulin, cells containing lipid droplets consistent with the overall morphological appearance of adipocytes were observed under the light microscope (see Fig. 3G ). Histological staining of differentiated cells with oil red O confirmed the presence of lipid within the intracellular vesicles (data not shown). On the other hand, cells grown in the absence of inducing agents had the morphological appearance of fibroblasts without lipid droplets (data not shown).
Inhibition of Leptin Secretion by ATP-Previous studies reported that differentiated adipocytes secreted leptin into the incubation medium in response to insulin (20) . To investigate the effect of purinergic activation on the insulin-induced leptin secretion from white adipocytes, we treated cells with 300 M ATP. Time course studies demonstrated that insulin-induced leptin secretion occurred in a time-dependent manner, which was suppressed by ATP treatment (Fig. 1A) . This suggests that the purinergic receptor may be a negative regulator of leptin secretion. Fig. 1B shows that BzATP, an analog of ATP, also suppressed the insulin-induced leptin secretion under the same conditions, whereas UTP had little effect. It is well known that glucocorticoids stimulate leptin secretion (31), whereas cAMP and cAMP-dependent protein kinase A antagonize insulinstimulated leptin secretion (13) . synthetic glucocorticoid, dexamethasone, enhanced leptin secretion, whereas forskolin, an activator of adenylyl cyclase, and isoproterenol, a ␤-adrenergic receptor agonist, reduced leptin secretion. To determine whether the inhibitory effect of purinergic receptor activation is due to blocking early insulin signaling or leptin synthesis, we examined the effect of ATP analogs on dexamethasone-induced leptin secretion. Fig. 1C shows that the nucleotides also reduced leptin secretion induced by dexamethasone, implying that the inhibitory role of purinergic receptor is via leptin synthesis but not the early insulin signaling pathway. (Fig. 2A) . To determine the effects of ATP on phospholipase C activation, we stimulated the differentiated adipocytes with ATP and examined the turnover of phosphoinositides. ATP caused concentration-dependent IP 3 formation in the cells with an EC 50 and a maximum effective concentration of 10 Ϯ 3 and 300 Ϯ 11 M, respectively (Fig. 2B) . The time course of IP 3 production induced by maximally effective concentration (300 M) of ATP shows that addition of ATP to the cells evoked a rapid increase in the level of IP 3 that peaked at 30 s after ATP addition and then declined to the basal level (Fig. 2C) . These results clearly suggest that phospholipase C-coupled P2 receptors were expressed in the differentiated adipocytes. To determine whether adenylyl cyclase-coupled P2 receptors were also expressed, we measured changes in cAMP contents upon ATP treatment. Treatment of cells with ATP (300 M) increased cAMP contents by ϳ13-fold, suggesting the presence of adenylyl cyclase-coupled P2 receptors (Table I) . Table I ] i characterized by a rapid rise followed by a slow decrease. As seen in Fig. 3 (A-D) , addition of 300 M ATP produced a highly localized rise in intracellular calcium in the perinuclear region of the cell. This could be attributed to the greater cytoplasmic volume near the nucleus compared with the lipid droplet-enriched cytoplasm. Moreover, the three-dimensional surface plots of images A and B clearly show the intracellular heterogeneity of calcium increase in individual adipocytes (Fig. 3, E and F) .
Characterization of Purinergic Receptors in White Adipocytes-To characterize the pharmacological properties of the P2 receptors in white adipocytes, the potency of ATP, UTP, and BzATP for intracellular calcium mobilization and cAMP generation was compared. ATP and UTP were equally effective in elevating the intracellular calcium level, whereas BzATP had no effect, strongly suggesting that the nucleotide receptor in white adipocytes is the P2Y 2 subtype (33) (Fig. 4A) . In contrast, potent effects of ATP and BzATP on the accumulation of cAMP, and the minor effect of UTP, suggest the presence of the P2Y 11 subtype (Fig. 4B) . The relative potency of these nucleotides in activating adenylyl cyclase is characteristic of the P2Y 11 subtype (34, 35) . Moreover, addition of the P2X receptor-selective agonist ␣,␤MeATP (300 M) (36) had no effect on elevating [Ca 2ϩ ] i (Table I) . These results suggest that at least two subtypes of the P2 purinergic receptor, P2Y 2 and P2Y 11 , are expressed in differentiated white adipocytes.
Phosphorylation of p38 and CREB by UTP and BzATP Stimulation-To further explore the differences in the signaling pathways mediated by P2Y 2 and P2Y 11 receptors in adipocytes, we investigated the pattern of MAP kinase and CREB phosphorylation activated by UTP and BzATP. Fig. 5 shows that ERK was transiently phosphorylated by both UTP and BzATP. JNK was also transiently activated by both nucleotides similar to ERK activation. Treatment of cells with BzATP led to a time-dependent phosphorylation of CREB but not p38. The level of phosphorylation reached its maximum after 10 min and returned to the basal level after 30 min. In contrast, UTP did not induce phosphorylation of CREB but led to time-dependent phosphorylation of p38. The results strongly suggest that two distinct purinergic signals were activated by treatment of adipocytes with ATP. concentration-dependent manner. BzATP was slightly more potent than ATP, but UTP had no effect (Fig. 6) . The effects of the nucleotides on leptin secretion correlated with the pattern of cAMP production (Fig. 4B) . Previous studies also showed that activation of G s -coupled ␤-adrenergic receptors decreased not only leptin secretion but also leptin gene expression (31, 37) . To examine whether the inhibition of leptin secretion by purinergic stimulation was regulated transcriptionally, we isolated total RNA from the cells treated with ATP, UTP, or BzATP in the presence of insulin for 24 h and performed Northern blot analysis. As shown in Fig. 7 (A and B) , insulininduced leptin gene expression was decreased by treatment with ATP or BzATP. However, there was no significant difference between control and UTP-treated cells. Forskolin also inhibited leptin gene expression, whereas dexamethasone increased the leptin mRNA level by ϳ10-fold compared with the untreated control. To confirm the inhibitory effect of purinergic receptor activation on leptin gene expression, we conducted quantitative real-time reverse transcription-PCR. As shown in Fig. 7C , ATP and BzATP significantly suppressed not only insulin-mediated leptin mRNA expression but also basal leptin levels. These results suggest that the P2Y 11 receptor may have a crucial role in the regulation of leptin gene expression.
Effects of Purinergic Stimulation on Leptin Secretion and Leptin Gene Expression-Addition
Effects of Purinergic Stimulation on HSL Translocation and Lipolysis-In adipocytes, lipolysis is another important physiological process that can be activated by cAMP-elevating signals. Various agents known to increase intracellular cAMP such as forskolin, pertussis toxin, and ACTH stimulate lipolysis in the range of concentrations at which they inhibit insulinstimulated leptin secretion (38) . Elevation of intracellular cAMP activates cAMP-dependent protein kinase A, which, in turn, phosphorylates HSL, the rate-limiting enzyme catalyzing lipolysis (54) . Phosphorylation of HSL promotes the translocation of the enzyme from a cytosolic location to the surface of the lipid droplet (55) . We examined the location of HSL in ATPstimulated and unstimulated adipocytes by immunoblotting after subcellular fractionation. In unstimulated cells, the majority of HSL was found in the cytosolic fraction of homogenates (Fig. 8A) . When cells were stimulated with 300 M ATP for 30 min, a significant amount of HSL was associated with floating lipid droplets. Thus, HSL that has been translocated to the floating lipid droplets in stimulated cells remains bound to the droplets during homogenization and subcellular fractionation of the cells, suggesting a tight association of the lipase with the droplet upon ATP stimulation. The anti-HSL antibodies showed specificity in binding to a major band at 84 kDa and a minor band at ϳ86 kDa in immunoblots of both control and stimulated adipocytes (Fig.  8A) , similar to the recent findings observed in primary murine, rat, and human adipocytes (56) . To examine whether purinergic stimulation was involved in lipolysis, we monitored lipolytic activity by measuring glycerol release. As seen in Fig. 8B , incubation of adipocytes with ATP, BzATP, and UTP increased lipolysis in a time-dependent manner. The marked increase in lipolytic activity was observed within 30 min of incubation with each nucleotide. Unexpectedly, UTP significantly increased the lipolytic activity, suggesting that UTP may also trigger the lipolytic process through a cAMPindependent pathway. Collectively, these results suggest that purinergic receptors prominently activate lipolysis in white adipocytes.
DISCUSSION
The present study reveals the purinergic signaling system as a novel regulator of lipolysis and leptin production in rat white adipocytes. Time course studies demonstrated that ATP markedly inhibited leptin secretion induced by insulin. An analog of ATP, BzATP, also reduced the insulin-induced leptin secretion as ATP. In addition, the results from Northern blot analysis and quantitative real-time reverse transcription-PCR revealed that insulin-induced leptin gene expression was strongly inhibited by ATP or BzATP. On the other hand, lipolytic activity in rat white adipocytes was markedly increased by ATP, BzATP, and UTP. These findings in rat white adipocytes suggest that purinergic receptors have dual functions, i.e. suppressing leptin gene expression and activating lipolysis.
Many studies have suggested that more than one subtype of P2 purinergic receptors can be expressed in a single cell type (23, 39, 40) . Here we show that at least two subtypes of purinergic receptors are expressed in differentiated white adipocytes. The pharmacological profiles of the nucleotide-induced Ca 2ϩ responses and IP 3 generation indicate that extracellular ATP and UTP are equipotent activators, which is consistent with the pharmacological characteristics of the P2Y 2 receptor subtype (41) . The presence of the P2Y 11 subtype in differentiated adipocytes was suggested by a previous study in which ATP␥S and BzATP were shown to be more potent agonists than ATP in elevating cAMP content, whereas UTP had no such effect (35) . Moreover, our results show that phosphorylation of p38 and CREB are differentially regulated by UTP and BzATP. We suggest that BzATP and UTP do not act on the same receptor population, i.e. they do not act as partial agonists for a single receptor in adipocytes. These results support the conclusion that the responses to UTP and BzATP are mediated via separate P2 purinergic receptors, P2Y 2 and P2Y 11 , respectively. In line with the results from differentiated adipocytes, studies with isolated adipocytes from rat epididymal fat fads also showed the pharmacological characteristics of the P2Y 2 and P2Y 11 receptors in terms of regulating both intracellular calcium increase (Supplemental Fig. S1 ) and glycerol release (Supplemental Fig. S2) , thereby excluding the effects of remaining fibroblasts in the differentiated adipocyte culture. These results further support the evidence that functional P2Y 2 and P2Y 11 purinoceptors are expressed in mature adipocytes.
Previous studies have shown that expression of leptin mRNA and protein was influenced by intracellular cAMP concentrations (31, 37) and that leptin secretion from white adipocytes was highly dependent upon its continuous synthesis and transcription (42) . In addition, it has been reported that the G scoupled ␤ 3 -adrenergic receptor inhibits leptin secretion from isolated rat adipocytes by activation of cAMP-dependent protein kinase (13) . Our data show that insulin-stimulated leptin synthesis and its subsequent release from primary cultured adipocytes can be completely blocked by activating purinergic receptors. These findings are consistent with a previous report showing that increased cAMP reduced basal leptin release from overnight cultures of rat adipocytes (31) . Furthermore, our study extends these findings to the involvement of P2Y 11 in inhibition of leptin secretion by showing that the effect of BzATP is more potent than ATP, whereas UTP has no effect on the inhibition of insulin-induced leptin secretion. Results showing that ATP and BzATP potently activate lipolysis with a corresponding decrease in the level of leptin support the involvement of P2Y 11 receptor. However, UTP also caused significant increase in lipolysis without a corresponding decrease in leptin level, which implies that another UTP-sensitive P2Y receptor might be involved in a cAMP-independent manner.
In the study of P2 purinergic receptors, the absence of high affinity antagonists makes it difficult to define precisely the cellular function of different receptor subtypes (43) . Until now, most of the studies suggesting subtype-specific purinergic signaling have relied on the potency order of nucleotides affecting second messenger generation. Our data clearly show that the P2Y 11 , which is coupled to adenylyl cyclase, is involved in the regulation of both leptin secretion and lipolysis in differentiated white adipocytes. To our knowledge, this pharmacological evidence satisfies the requirements for the presence of P2Y 11 in white adipocytes. However, the cloning of rat P2Y 11 receptor gene is also required to confirm expression of the P2Y 11 subtype in white adipocytes.
Our work reveals that purinergic receptors have dual effects, which are inhibitory for leptin synthesis and stimulatory for lipolysis in white adipocytes. In fact, in addition to purinergic receptor agonists, many agonists that have inhibitory effects on insulin-stimulated leptin synthesis also have stimulatory effects on lipolysis in adipocytes. A wide range of agents known to increase intracellular cAMP levels by stimulating its production with the activation of adenylyl cyclase, inhibiting its degradation by blocking phosphodiesterases, or mimicking its action with cell-permeable cAMP analogs, all suppressed insulininduced leptin secretion and concomitantly stimulated lipolysis and fatty acid release (38) . Physiological conditions such as starvation and cold exposure also stimulate lipolysis through activation of the sympathetic nervous system and decrease plasma leptin concentration in adipose tissue (12, 44) . Thus, cAMP plays a fundamental role in regulating leptin secretion, and it is likely that, under the physiological conditions mentioned above, norepinephrine and other lipolytic hormones counter-regulate the stimulatory effects of insulin on leptin secretion by activating the adenylyl cyclase system. The possibility that long-chain fatty acids might play a messenger role linking lipolysis and inhibition of leptin secretion has been carefully suggested. For example, long-chain fatty acids such as palmitic (C16) and stearic (C18) acids mimic the inhibitory effects of norepinephrine on leptin secretion (46) . Intracellular free fatty acid accumulation by treatment with an acyl-CoA synthetase inhibitor, triacsin C, also reduced ob gene expression (47) . However, it remains to be elucidated whether there is a cause and effect relationship between stimulation of lipolysis and inhibition of leptin secretion.
It is has been well established that the sympathetic nervous system innervates white adipose tissue and contributes to the control of fat pad mass and fat cell number (48, 49) . Moreover, norepinephrine and ATP are colocalized in the sympathetic nerve terminals and released simultaneously in response to neuronal activity (15, 50) . Much of the early evidence implicating ATP as a cotransmitter came from studies of smooth muscle in vas deferens and blood vessels as well as the skeletal neuromuscular junction (52, 53) . ATP and norepinephrine released from sympathetic nerves have synergistic actions on smooth muscle of vas deferens and blood vessels, and ATP released from motoneurons facilitates the nicotinic actions of acetylcholine at the skeletal neuromuscular junction. Our present results suggesting that ATP and norepinephrine have similar effects on leptin synthesis and lipolysis raise the possibility that ATP acts as a cotransmitter with norepinephrine in white adipose tissue, which is innervated by the sympathetic nervous system.
In summary, we suggest that ATP increases intracellular calcium and cAMP levels through activation of two separate purinergic receptors, coupled to phospholipase C and adenylyl cyclase, respectively. Additionally, we show that stimulation of purinergic receptors results in suppression of insulin-mediated leptin secretion and activation of lipolysis. To our knowledge, the present results are the first to establish that the purinergic signaling system has dual functions, which are inhibition of insulin-induced leptin production and activation of lipolysis in rat white adipocytes. Discovery of the ␤ 3 -adrenergic receptor, which mediates lipolysis, has prompted numerous groups to seek additional ␤ 3 -adrenergic receptor agonists with high affinity and specificity for the possibility of treating obesity. Likewise, the presence of purinergic receptors, which induce potent lipolytic processes, suggests other prime molecular candidates for an anti-obesity strategy.
